FDA Warning Letter — IDO PHARM
The FDA took a Warning Letter action against IDO PHARM on May 4, 2026 (Ansan, South Korea). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.
Action Details
- Facility
- IDO PHARM
- Date
- May 4, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Center
- CDER
- Location
- Ansan (South Korea)